(Q57499315)
Statements
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease (English)
0 references
21
0 references
2
0 references
101-7
0 references
scholarly article published in Clinical Neuropharmacology